| 2 Einträge |
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. | |
| Autoren | Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| Erscheinungsdaten | The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| Publikations ID | PMID: 29146401 |
| Evolutionary loss of complexity in human vocal anatomy as an adaptation for speech. | |
| Autoren | Nishimura T, Tokuda IT, Miyachi S, Dunn JC, Herbst CT, Ishimura K, Kaneko A, Kinoshita Y, Koda H, Saers JPP, Imai H, Matsuda T, Larsen ON, Jürgens U, Hirabayashi H, Kojima S, Fitch WT |
| Erscheinungsdaten | Science (New York, N.Y.). 2022 Aug 11. doi: 10.1126/science.abm1574 |
| Publikations ID | PMID: 35951711 |